Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1030 clinical trials
featured
Research Study for Chronic Obstructive Pulmonary Disease (COPD)

Research Study for Chronic Obstructive Pulmonary Disease (COPD)

  • 76 views
  • 08 Nov, 2020
  • 1 location
featured
COPD (Chronic Obstructive Pulmonary Disease)

COPD (Chronic Obstructive Pulmonary Disease)

  • 104 views
  • 08 Nov, 2020
  • 1 location
featured
Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease (COPD)

  • 606 views
  • 08 Nov, 2020
  • 1 location
featured
A Phase 3 clinical study for patients with moderate to severe Chronic Obstructive Pulmonary Disease (COPD).

A Phase 3 clinical study for patients with moderate to severe Chronic Obstructive Pulmonary Disease (COPD).

  • 248 views
  • 08 Nov, 2020
  • 1 location
featured
A Phase 4 clinical study for patients with moderate to severe Chronic Obstructive Pulmonary Disease (COPD) who experience COPD exacerbations.

A Phase 4 clinical study for patients with moderate to severe Chronic Obstructive Pulmonary Disease (COPD) who experience COPD exacerbations.

  • 166 views
  • 08 Nov, 2020
  • 1 location
featured
Do you have COPD* (Chronic Obstructive Pulmonary Disease)

Do you have COPD* (Chronic Obstructive Pulmonary Disease)

  • 588 views
  • 23 Nov, 2020
  • 1 location
featured
Chronic Bronchitis or Emphysema-also known as Chronic Obstructive Pulmonary Disease which is most often caused by cigarette smoking.

Chronic Bronchitis or Emphysema-also known as Chronic Obstructive Pulmonary Disease which is most often caused by cigarette smoking.

  • 1406 views
  • 08 Nov, 2020
  • 1 location
featured
Now Enrolling - Chronic Obstructive Pulmonary Disease (COPD) Research Study

Now Enrolling - Chronic Obstructive Pulmonary Disease (COPD) Research Study

  • 342 views
  • 23 Nov, 2020
  • 3 locations
featured
A Phase II, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Lebrikizumab in Patients with Chronic Obstructive Pulmonary Disease and a History of Exacerbations

A Phase II, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Lebrikizumab in Patients with Chronic Obstructive Pulmonary Disease and a History of Exacerbations

  • 242 views
  • 08 Nov, 2020
  • 1 location
featured
A 24-week treatment, multi-center, randomized, double-blind, double-dummy, parallel group study to compare Umeclidinium/Vilanterol, Umeclidinium, and Salmeterol in subjects with chronic obstructive pulmonary disease (COPD)

A 24-week treatment, multi-center, randomized, double-blind, double-dummy, parallel group study to compare Umeclidinium/Vilanterol, Umeclidinium, and Salmeterol in subjects with chronic obstructive pulmonary disease (COPD)

  • 568 views
  • 23 Nov, 2020
  • 1 location